Ratio logo — Developing innovative, pain-free transdermal solutions for e...

Ratio

Developing innovative, pain-free transdermal solutions for effective drug delivery.

Founded 2005 Angel Total: $564.50K Biotechnology, Health Care +1

General Information

Company Name Ratio
Founded Year 2005
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Ratio. To contact Ratio, visit ratiodrugdelivery.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ratio

Ratio is a medical device enterprise founded in 2005, headquartered in Monona, Wisconsin, and specializes in the creation and production of drug delivery pumps. The company's flagship offering is a disposable drug delivery pump that utilizes a non-electronic, hydrogel-based technology designed to administer large molecule drugs and various biologics into the skin through microneedles. With a focus on providing painless and active transdermal products, Ratio, Inc. operates in the Biotechnology and Health Care industries. The company received a $221.50K Angel Round investment on 01 January 2012, with Wisconsin Investment Partners and Stateline Angels as investors. Ratio's slogan, "Developing innovative, pain-free transdermal solutions for effective drug delivery," captures the essence of its mission.

Taxonomy: drug delivery, transdermal technology, innovation, hydrogel-based technology, microneedles, biologics, painless delivery, disposable pumps, large molecule drugs, startup, investor analysis, Monona, Wisconsin

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round $221.50K 2
Wisconsin Investment Partners, Stateline Angels
01 Jan 2012
Venture Round $343.00K 1
Golden Angels Investors
09 Jul 2010

Ratio Alternatives & Competitors

View All Alternatives
Ratio vs

Innovative biotechnology driving advanced biotherapeutics with enhanced efficacy and reduced side-ef...

5 employees
Biotechnology, Health Care
Ratio vs

Advancing the Safety and Precision of Injectable Drug Delivery Through Innovative Technology

Non Equity Assistance
1 employees
Health Care, Medical Devices
Ratio vs

We CARE. We CREATE. We DELIVER.

Grant
326 employees
Biotechnology, Health Care

FAQ About Ratio

Developing innovative, pain-free transdermal solutions for effective drug delivery.
Ratio was founded in 2005.
Ratio operates in Biotechnology, Health Care and Medical Devices. Its work centres on drug delivery, transdermal technology, innovation and hydrogel-based technology.
Ratio has completed 2 funding rounds, raising a total of $564.50K. The latest funding stage is Angel.
Top alternatives and competitors to Ratio include Concortis Biosystems Corp, Crisi Medical Systems, LTS Lohmann Therapie-Systeme AG, Mineed Technology Co., Ltd., Permeon Biologics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ratio and Concortis Biosystems Corp are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ratio, https://bouncewatch.com/company/ratio, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes